Published in J Affect Disord on February 12, 1996
Usefulness of Supportive Text Messages in the Treatment of Depressed Alcoholics | NCT01037868
Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry (2010) 1.29
The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy (2007) 1.03
Behavioral therapies for co-occurring substance use and mood disorders. Biol Psychiatry (2004) 0.97
Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study. BMC Psychiatry (2010) 0.92
Substance use disorders and suicide attempts in bipolar subtypes. J Psychiatr Res (2008) 0.90
Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders. J Child Adolesc Psychopharmacol (2008) 0.88
Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approach. J Psychiatr Pract (2011) 0.86
Excessive cannabis use is associated with earlier age at onset in bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2011) 0.85
Adjunctive psychosocial intervention following Hospital discharge for Patients with bipolar disorder and comorbid substance use: A pilot randomized controlled trial. Psychiatry Res (2015) 0.84
Increased suicidality in mania complicated by alcoholism. Psychiatry (Edgmont) (2007) 0.78
Substance use, symptom, and employment outcomes of persons with a workplace mandate for chemical dependency treatment. Psychiatr Serv (2009) 0.77
Bipolar Disorder in Neurologic Illness. Curr Treat Options Neurol (2002) 0.76
Cannabis and development of dual diagnoses: A literature review. Am J Drug Alcohol Abuse (2016) 0.75
Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder. CNS Drugs (2017) 0.75
Mood Disorders in Neurologic Illness. Curr Treat Options Neurol (2000) 0.75
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med (2000) 10.25
Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA (2001) 5.37
The Tridimensional Personality Questionnaire in depression: state versus trait issues. J Psychiatr Res (1996) 1.31
Chronicity of depressive episode in relation to antidepressant-placebo response. Neuropsychopharmacology (1991) 1.21
Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry (1994) 1.13
Panic disorder precipitated by exposure to organic solvents in the work place. Am J Psychiatry (1987) 1.12
Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry (1976) 1.11
Life events at the onset of bipolar affective illness. Am J Psychiatry (1979) 1.06
Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry (1974) 1.05
Life events and primary affective illness. Acta Psychiatr Scand (1978) 1.03
Rapid cycling manic depressive patients. Compr Psychiatry (1978) 1.03
Reduced catechol-O-methyltransferase activity in red blood cells of women with primary affective disorder. Science (1970) 1.01
Lithium response in unipolar versus bipolar depression. Am J Psychiatry (1972) 1.01
Heritable factors in the severity of affective illness. Biol Psychiatry (1976) 1.00
Rubidium: biochemical, behavioral, and metabolic studies in humans. Am J Psychiatry (1973) 1.00
Repetitive transcranial magnetic stimulation in the treatment of medication-resistant depression: preliminary data. J Nerv Ment Dis (1999) 0.99
Cardiac sinus node dysfunction during lithium treatment. Am J Psychiatry (1979) 0.97
Plasma DOPA response to levodopa administration in man: effects of a peripheral decarboxylase inhibitor. Clin Pharmacol Ther (1971) 0.95
The life table. A method for analyzing longitudinal studies. Arch Gen Psychiatry (1976) 0.95
Incidence of side effects in patients on long-term lithium therapy. Am J Psychiatry (1980) 0.94
Treatement of excessive weight gain in patients taking lithium. Am J Psychiatry (1976) 0.94
Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol Psychiatry (1978) 0.91
Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol (1995) 0.91
Lithium carbonate in affective disorders. IV. A double-blind study of prophylaxis in unipolar recurrent depression. Arch Gen Psychiatry (1975) 0.91
Relationship of childhood physical and sexual abuse to adult bipolar disorder. Bipolar Disord (2000) 0.91
Differential subtyping of depression. Depress Anxiety (2001) 0.90
Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry (1976) 0.90
Lithium erythrocyte: plasma ratio in primary affective disorder. Compr Psychiatry (1978) 0.89
Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. Am J Psychiatry (1973) 0.89
Lithium carbonate prophylaxis failure. Br J Psychiatry (1976) 0.88
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial. J Clin Psychiatry (2001) 0.88
Dawn simulation and bright light in the treatment of SAD: a controlled study. Biol Psychiatry (2001) 0.88
Statistical predictions of suicide in depressives. Compr Psychiatry (1980) 0.87
DSM-III-R personality disorders in a mood and anxiety disorders clinic: prevalence, comorbidity, and clinical correlates. J Affect Disord (1993) 0.87
Toward the validation of RDC schizoaffective disorder. Arch Gen Psychiatry (1980) 0.87
Morning or evening bright light treatment of winter depression? The significance of hypersomnia. Biol Psychiatry (1991) 0.86
The course of development of mania in patients with recurrent depression. Am J Psychiatry (1976) 0.86
Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients. Am J Psychiatry (1982) 0.85
Clinical and differential diagnostic aspects of treatment-resistant depression. J Psychiatr Res (1995) 0.85
Onset of response in relation to outcome in depressed outpatients with placebo and imipramine. J Affect Disord (1989) 0.85
Psychopathology in systemic lupus erythematosus. II. Relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4. Semin Arthritis Rheum (1973) 0.84
Relationship between borderline personality disorder and Axis I diagnosis in severity of depression and anxiety. J Clin Psychiatry (1999) 0.84
A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Ann Clin Psychiatry (1998) 0.84
Lithium treatment in older patients. Am J Psychiatry (1979) 0.83
Social outcome compared in psychotic and nonpsychotic bipolar I patients. J Nerv Ment Dis (1983) 0.83
Lactate vulnerability after alprazolam versus placebo treatment of panic disorder. Biol Psychiatry (1991) 0.83
Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. J Clin Psychiatry (1986) 0.82
Bipolar illness: a prospective study of life events. Compr Psychiatry (1977) 0.81
Psychiatric illness in fathers of men with bipolar primary affective disorder. Arch Gen Psychiatry (1975) 0.81
The effect of lithium treatment on thyroid function in patients with primary affective disorder. Am J Psychiatry (1979) 0.81
Unipolar mania: a distinct clinical entity? Am J Psychiatry (1979) 0.80
L-tryptophan in depression. Biol Psychiatry (1976) 0.80
Depressive symptoms in patients with unipolar and bipolar affective disorder. Compr Psychiatry (1976) 0.79
Secondary depression in anxiety disorders. Compr Psychiatry (1982) 0.79
Coping in panic and major depressive disorder. Relative effects of symptom severity and diagnostic comorbidity. J Nerv Ment Dis (1992) 0.79
Self and other directed violence on a closed acute-care ward. Psychiatr Q (1984) 0.79
Repression of a lithium pump as a consequence of lithium ingestion by manic-depressive subjects. Psychopharmacology (Berl) (1977) 0.79
The effect of L-DOPA treatment on brain serotonin metabolism in depressed patients. Life Sci I (1971) 0.79
Effect of L-tryptophan on brain serotonin metabolism in depressed patients. Arch Gen Psychiatry (1972) 0.79
Bright light treatment of winter depression: morning versus evening light. Acta Psychiatr Scand (1990) 0.79
Descriptive validity and stability of diagnostic criteria for dysthymic disorder. Compr Psychiatry (1996) 0.79
Dawn simulation treatment of winter depression: a controlled study. Am J Psychiatry (1993) 0.78
Mitral valve prolapse and the anxiety disorders. Hosp Community Psychiatry (1988) 0.78
Lactate infusions in major depression without panic attacks. J Psychiatr Res (1987) 0.78
Menstrual problems in women with primary affective illness. Compr Psychiatry (1976) 0.78
Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression. Pharmacopsychiatry (1989) 0.78
Cogwheel rigidity during chronic lithium therapy. Am J Psychiatry (1979) 0.78
Anxiety and panic: relationship to depression and cardiac disorders. Psychosomatics (1985) 0.78
Personality features of patients with primary affective disorder. Acta Psychiatr Scand (1979) 0.77
Biological markers in panic states: lactate-induced panic and mitral valve prolapse. Biol Psychiatry (1987) 0.77
Suicide attempts in rapid cycling bipolar disorder patients. J Affect Disord (1993) 0.77
The phenomenology of bipolar I manic-depressive illness. Can J Psychiatry (1982) 0.77
Lithium carbonate and weight gain. J Affect Disord (1980) 0.77
Assortative mating in primary affective disorder. Biol Psychiatry (1976) 0.77
Assortative mating in the affective disorders. Biol Psychiatry (1973) 0.77
Search for biological/genetic markers in a long-term epidemiological and morbid risk study of affective disorders. J Psychiatr Res (1984) 0.77
Age at onset and number of psychotic symptoms in bipolar I and schizoaffective disorder. Am J Psychiatry (1983) 0.77
Amino acid concentrations in cerebrospinal fluid: effects of aging, depression, and probenecid. Biol Psychiatry (1980) 0.77
Depression and axis II disorders: comorbidity and relationship to cooperativeness. Depress Anxiety (1997) 0.77
Age of onset of affective illness. Psychiatr Clin (Basel) (1982) 0.77
Lactate infusions: the role of baseline anxiety. Psychiatry Res (1987) 0.77
Plasma and erythrocyte magnesium levels in patients with primary affective disorder during chronic lithium treatment. Acta Psychiatr Scand (1975) 0.77
Lithium elimination half-life and duration of therapy. Clin Pharmacol Ther (1981) 0.77
A report on three patients with "rapid cycling" unipolar depression. Compr Psychiatry (1992) 0.77
Sub-types of bipolar affective disorder with particular regard to bipolar II. Psychiatr Dev (1983) 0.77
Differentiation of anxious patients by two-dimensional echocardiographic evaluation of the mitral valve. Am J Psychiatry (1986) 0.76
The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder. Am J Psychiatry (1985) 0.76
Suicide attempt history in depressed patients with and without a history of panic attacks. Compr Psychiatry (1995) 0.76
A report of trazodone-associated laboratory abnormalities. Ther Drug Monit (1990) 0.76
Psychosis as a predictor of response to lithium maintenance treatment in bipolar affective disorder. J Affect Disord (1979) 0.76
Characteristics of placebo response during long-term treatment of panic disorder. Psychopharmacol Bull (1990) 0.76
Response to lactate infusion in generalized anxiety disorder. Biol Psychiatry (1988) 0.76
Early placebo response in anxious and depressed patients. J Clin Psychiatry (1986) 0.76
Prophylactic effect of lithium against depression in cyclothymic patients: a life-table analysis. Compr Psychiatry (1981) 0.76
Diagnostic reliability of M-mode echocardiography for detecting mitral valve prolapse in 50 consecutive panic patients. Compr Psychiatry (1989) 0.76
Classification of bipolar affective disorder subtypes. Compr Psychiatry (1982) 0.76
Response to sodium lactate in panic disorder: relationship to presenting clinical variables. Psychiatry Res (1988) 0.76
Differential catechol-O-methyltransferase activity in unipolar and bipolar affective illness. Arch Gen Psychiatry (1971) 0.76
Treatment resistance in unipolar depression and other disorders. Diagnostic concerns and treatment possibilities. Psychiatr Clin North Am (1993) 0.76
The relationship between anxiety and depression: a clinical comparison of generalized anxiety disorder, dysthymic disorder, panic disorder, and major depressive disorder. Compr Psychiatry (1992) 0.75